Riboflavin ophthalmic solution regulatory update

FDA’s Dermatologic and Ophthalmic Drugs and Ophthalmic Devices Panel of the Medical Devices advisory committees voted in support of approval of Avedro’s riboflavin ophthalmic solution with UVA irradiation. The product is under review for use in corneal collagen cross-linking for the treatment of the conditions underlying progressive keratoconus or corneal ectasia following refractive surgery. The PDUFA date is March 29. ...